Growth hormone pathway

1
Assets
1
Companies

Target Biology

Competitive Landscape

Asset Company Stage Mechanism Lead Indication Ownership
TransCon_hGH ASND Phase 2 Growth hormone therapy that presses the accelerator by recruiting stem cells and increasing chondrocyte numbers

Companies

ASND 1 asset(s)
Phase 2
← Back to All Targets